Hyperglycemia affects the bioavailability of nitric oxide and increases the number of oxygen radicals and endothelium-derived vasoconstrictors such as endothelin-1, prostanoids, and angiotensin II (16). The gene discussed is EDN1; the disease is Hyperglycemia.